GLYCERIN SUPPOSITORIES

GLYCERIN SUPPOSITORIES was reported 2689 times

GLYCERIN SUPPOSITORIES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 155 0.5116
1 EOSINOPHIL COUNT NORMAL 3 0.2143
2 FIBULA AGENESIS 4 0.1600
3 HAEMOPHILUS SEPSIS 6 0.1053
4 FEMALE GENITAL TRACT FISTULA 158 0.0925
5 MULTIPLE DRUG THERAPY 54 0.0716
6 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
7 AUTOIMMUNE ENTEROPATHY 6 0.0682
8 CHRONIC SINUSITIS 227 0.0604
9 SEDATION COMPLICATION 153 0.0599
10 RADICULOPATHY 155 0.0588
11 PROCTITIS 156 0.0556
12 MACULAR DEGENERATION 599 0.0501
13 CREATININE RENAL CLEARANCE DECREASED 163 0.0407
14 SPINA BIFIDA OCCULTA 4 0.0381
15 GALLBLADDER ADENOCARCINOMA 2 0.0282
16 BACTERIAL TRACHEITIS 2 0.0247
17 TRACHEOSTOMY INFECTION 3 0.0246
18 INFANT IRRITABILITY 2 0.0204
19 FALSE POSITIVE INVESTIGATION RESULT 19 0.0188
20 ANAL EROSION 2 0.0182
21 OESOPHAGEAL INJURY 7 0.0181
22 CLOSTRIDIUM DIFFICILE SEPSIS 2 0.0179
23 POSITIVE AIRWAY PRESSURE THERAPY 5 0.0171
24 INCARCERATED INGUINAL HERNIA 2 0.0164
25 MYELOCYTE COUNT INCREASED 3 0.0160
26 VAGINAL DISCHARGE 155 0.0153
27 BLOOD TESTOSTERONE FREE DECREASED 2 0.0153
28 RENAL FUNCTION TEST ABNORMAL 69 0.0148
29 NASAL FLARING 2 0.0148
30 BLOOD CALCIUM DECREASED 166 0.0147
31 PARAESTHESIA ORAL 212 0.0147
32 METAMYELOCYTE COUNT INCREASED 2 0.0134
33 LACK OF ADMINISTRATION SITE ROTATION 4 0.0131
34 BACTERIAL TRANSLOCATION 4 0.0126
35 ORAL CANDIDIASIS 158 0.0120
36 TOOTH DEPOSIT 4 0.0115
37 BILE ACIDS INCREASED 2 0.0113
38 ENCOPRESIS 2 0.0103
39 FAT TISSUE DECREASED 4 0.0103
40 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
41 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
42 RENAL ABSCESS 8 0.0098
43 ORTHOSTATIC HYPOTENSION 167 0.0096
44 HAEMORRHAGIC EROSIVE GASTRITIS 3 0.0092
45 FEEDING INTOLERANCE 4 0.0089
46 MAGNESIUM DEFICIENCY 4 0.0085
47 KIDNEY MALFORMATION 3 0.0085
48 IDIOPATHIC INTERSTITIAL PNEUMONIA 3 0.0085
49 NEUROGENIC BOWEL 2 0.0084
50 BRAIN NEOPLASM BENIGN 4 0.0078
51 ALLERGIC COUGH 6 0.0078
52 INJECTION RELATED REACTION 12 0.0073
53 USE OF ACCESSORY RESPIRATORY MUSCLES 3 0.0073
54 PROCEDURAL PAIN 197 0.0071
55 HYPOAESTHESIA EYE 4 0.0068
56 NEPHRITIC SYNDROME 2 0.0065
57 RED BLOOD CELLS URINE POSITIVE 6 0.0062
58 SUPERINFECTION 9 0.0060
59 SEDATION 157 0.0060
60 FREQUENT BOWEL MOVEMENTS 160 0.0059
61 CHRONIC RESPIRATORY DISEASE 2 0.0057
62 ANISOCORIA 2 0.0053
63 VOLVULUS 12 0.0051
64 ALVEOLAR OSTEITIS 2 0.0047
65 HYPERMAGNESAEMIA 3 0.0046
66 COLITIS 170 0.0045
67 DEPRESSED LEVEL OF CONSCIOUSNESS 177 0.0045
68 IMMUNE-MEDIATED HYPOPHYSITIS 2 0.0044
69 IMMUNOGLOBULINS INCREASED 2 0.0043
70 KLEBSIELLA BACTERAEMIA 4 0.0042
71 ANTIBODY TEST ABNORMAL 3 0.0042
72 OROMANDIBULAR DYSTONIA 3 0.0041
73 BLOOD CORTICOTROPHIN DECREASED 2 0.0041
74 ASTIGMATISM 6 0.0040
75 TRACHEITIS 3 0.0039
76 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 3 0.0038
77 BLOOD FIBRINOGEN INCREASED 3 0.0038
78 RECTAL HAEMORRHAGE 163 0.0038
79 FAECAL VOMITING 2 0.0038
80 COGNITIVE DISORDER 171 0.0037
81 COLITIS ULCERATIVE 160 0.0036
82 PSEUDOMONAL BACTERAEMIA 3 0.0035
83 CARBON DIOXIDE DECREASED 4 0.0035
84 PUSTULE 8 0.0034
85 GASTROINTESTINAL BACTERIAL OVERGROWTH 2 0.0033
86 INFUSION RELATED REACTION 214 0.0032
87 BILIARY TRACT INFECTION 2 0.0032
88 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 228 0.0032
89 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
90 HAEMATOCHEZIA 169 0.0031
91 PYELONEPHRITIS ACUTE 6 0.0031
92 FEELING OF RELAXATION 2 0.0029
93 SUBILEUS 6 0.0029
94 RHINOVIRUS INFECTION 11 0.0028
95 ENDOMETRIAL CANCER 6 0.0027
96 CLOSTRIDIUM TEST POSITIVE 6 0.0027
97 AORTIC ARTERIOSCLEROSIS 7 0.0027
98 LOCAL REACTION 2 0.0027
99 HYPOPROTEINAEMIA 5 0.0026
100 GASTROINTESTINAL SURGERY 2 0.0026
101 BILIRUBIN CONJUGATED INCREASED 6 0.0026
102 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 2 0.0026
103 HYPOCHLORAEMIA 3 0.0026
104 FOETAL GROWTH RETARDATION 2 0.0026
105 METAPNEUMOVIRUS INFECTION 2 0.0026
106 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
107 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
108 MONOCYTE COUNT DECREASED 3 0.0025
109 TUMOUR HAEMORRHAGE 7 0.0025
110 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
111 INTRA-ABDOMINAL HAEMATOMA 3 0.0024
112 MOBILITY DECREASED 174 0.0024
113 ENTEROVIRUS INFECTION 2 0.0023
114 BLADDER DISORDER 23 0.0023
115 BLOOD CHLORIDE INCREASED 4 0.0023
116 TUMOUR PAIN 3 0.0023
117 INTESTINAL DILATATION 3 0.0022
118 PSEUDOMEMBRANOUS COLITIS 5 0.0022
119 GASTROINTESTINAL INJURY 6 0.0022
120 FAECALOMA 12 0.0022
121 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
122 DIABETIC FOOT INFECTION 3 0.0021
123 DYSPEPSIA 207 0.0021
124 INJECTION SITE HYPOAESTHESIA 3 0.0021
125 POST HERPETIC NEURALGIA 3 0.0021
126 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
127 ANIMAL SCRATCH 2 0.0021
128 CONSTIPATION 448 0.0021
129 NEUTROPHIL COUNT INCREASED 21 0.0020
130 PSYCHIATRIC DECOMPENSATION 4 0.0020
131 MASTOIDITIS 2 0.0020
132 RESPIRATORY ACIDOSIS 8 0.0020
133 BALANCE DISORDER 174 0.0020
134 LUNG ADENOCARCINOMA 6 0.0020
135 BRONCHIOLITIS 7 0.0020
136 SMALL CELL LUNG CANCER 3 0.0020
137 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
138 KLEBSIELLA INFECTION 10 0.0020
139 EYE ALLERGY 3 0.0019
140 BLOOD PHOSPHORUS DECREASED 7 0.0019
141 HEPATITIS E 3 0.0019
142 TINEA PEDIS 3 0.0019
143 NEUROMYOPATHY 2 0.0019
144 KIDNEY ENLARGEMENT 2 0.0018
145 INFLAMMATORY MARKER INCREASED 9 0.0018
146 TROPONIN I INCREASED 3 0.0018
147 TONGUE BLISTERING 4 0.0018
148 ILEUS PARALYTIC 8 0.0018
149 ENTERITIS INFECTIOUS 3 0.0018
150 MOUTH SWELLING 10 0.0017
151 HYPERURICAEMIA 7 0.0017
152 INCISION SITE PAIN 2 0.0017
153 FACIAL PARESIS 6 0.0017
154 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
155 SCHIZOAFFECTIVE DISORDER 3 0.0017
156 INFECTED CYST 2 0.0017
157 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
158 CHRONIC RESPIRATORY FAILURE 2 0.0017
159 HYPERNATRAEMIA 8 0.0016
160 ADENOCARCINOMA OF COLON 3 0.0016
161 NECROTISING COLITIS 2 0.0016
162 RADIOTHERAPY 3 0.0016
163 PNEUMONIA VIRAL 5 0.0016
164 ANAEMIA POSTOPERATIVE 2 0.0015
165 LYMPHOCYTE COUNT DECREASED 27 0.0015
166 PNEUMONIA ASPIRATION 38 0.0015
167 OTITIS MEDIA 5 0.0015
168 BLOOD SODIUM INCREASED 4 0.0015
169 ABDOMINAL RIGIDITY 4 0.0015
170 NASAL DISCHARGE DISCOLOURATION 2 0.0014
171 BUNDLE BRANCH BLOCK LEFT 6 0.0014
172 INTENSIVE CARE 2 0.0014
173 PROTEIN URINE PRESENT 7 0.0014
174 PNEUMATOSIS INTESTINALIS 4 0.0014
175 NEUROLOGICAL SYMPTOM 8 0.0014
176 BLOOD ALBUMIN DECREASED 11 0.0014
177 PYELONEPHRITIS 12 0.0014
178 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
179 GINGIVAL SWELLING 6 0.0014
180 CONJUNCTIVITIS ALLERGIC 2 0.0013
181 DECUBITUS ULCER 11 0.0013
182 TEMPERATURE REGULATION DISORDER 3 0.0013
183 LARGE INTESTINAL OBSTRUCTION 3 0.0013
184 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
185 CALCULUS URINARY 2 0.0013
186 ANAL ABSCESS 7 0.0013
187 FUNGAEMIA 2 0.0013
188 INGROWING NAIL 3 0.0013
189 URINE OUTPUT DECREASED 11 0.0013
190 COSTOCHONDRITIS 2 0.0012
191 BRADYARRHYTHMIA 2 0.0012
192 ANAEMIA 232 0.0012
193 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
194 ILEUS 15 0.0012
195 SKIN REACTION 17 0.0012
196 FLUID INTAKE REDUCED 6 0.0012
197 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
198 ABSCESS LIMB 5 0.0012
199 GLIOBLASTOMA 2 0.0012
200 PSEUDOMONAS INFECTION 10 0.0012
201 METASTASES TO CENTRAL NERVOUS SYSTEM 15 0.0012
202 LUNG OPACITY 3 0.0011
203 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
204 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
205 LARYNGOSPASM 3 0.0011
206 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
207 STOMA SITE DISCHARGE 3 0.0011
208 ESSENTIAL HYPERTENSION 2 0.0011
209 CONDUCTION DISORDER 2 0.0011
210 GASTROINTESTINAL PAIN 12 0.0011
211 PROCTALGIA 7 0.0011
212 UROSEPSIS 10 0.0011
213 ABDOMINAL PAIN 252 0.0011
214 RASH MORBILLIFORM 3 0.0011
215 DEMENTIA 30 0.0011
216 HYDRONEPHROSIS 8 0.0011
217 BLOOD IRON INCREASED 2 0.0011
218 PROTEIN TOTAL DECREASED 4 0.0011
219 PARANASAL SINUS DISCOMFORT 4 0.0011
220 GINGIVAL RECESSION 2 0.0010
221 TOXICITY TO VARIOUS AGENTS 175 0.0010
222 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
223 GASTROINTESTINAL NECROSIS 3 0.0010
224 STAPHYLOCOCCAL SEPSIS 5 0.0010
225 ERYTHEMA 208 0.0010
226 HEPATITIS FULMINANT 3 0.0010
227 CEREBRAL ATROPHY 4 0.0010
228 URINE ANALYSIS ABNORMAL 3 0.0010
229 ANORECTAL DISORDER 2 0.0010
230 BLOOD CULTURE POSITIVE 3 0.0010
231 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
232 HYPOTENSION 197 0.0010
233 DYSAESTHESIA 3 0.0010
234 WEIGHT DECREASED 272 0.0010
235 DIVERTICULAR PERFORATION 2 0.0010
236 GASTROINTESTINAL PERFORATION 4 0.0010
237 INFUSION SITE SWELLING 6 0.0010
238 EOSINOPHILIC PNEUMONIA 3 0.0010
239 UPPER GASTROINTESTINAL HAEMORRHAGE 16 0.0010
240 NEUROGENIC BLADDER 2 0.0009
241 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
242 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
243 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
244 SKIN EROSION 3 0.0009
245 TEARFULNESS 4 0.0009
246 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
247 PYREXIA 315 0.0009
248 ASTHENOPIA 5 0.0009
249 GASTRIC ULCER HAEMORRHAGE 5 0.0009
250 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
251 HYPOALBUMINAEMIA 7 0.0009
252 RHINITIS ALLERGIC 4 0.0009
253 BACTERIAL TEST POSITIVE 2 0.0009
254 SKIN INFECTION 10 0.0009
255 COLITIS ISCHAEMIC 6 0.0009
256 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
257 HAEMATOCRIT INCREASED 2 0.0009
258 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
259 WOUND COMPLICATION 3 0.0009
260 ENTEROCOLITIS 5 0.0009
261 HYPOCALCAEMIA 16 0.0008
262 DIVERTICULUM 6 0.0008
263 FIBRIN D DIMER INCREASED 3 0.0008
264 BLOOD UREA INCREASED 14 0.0008
265 LACUNAR INFARCTION 2 0.0008
266 NON-SMALL CELL LUNG CANCER 4 0.0008
267 LONG QT SYNDROME 2 0.0008
268 INFUSION SITE ERYTHEMA 7 0.0008
269 ATELECTASIS 8 0.0008
270 MONOCYTE COUNT INCREASED 3 0.0008
271 BRONCHITIS CHRONIC 2 0.0008
272 THROMBOCYTOSIS 3 0.0008
273 BREATH SOUNDS ABNORMAL 4 0.0008
274 ACUTE PSYCHOSIS 2 0.0008
275 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
276 BRAIN OEDEMA 10 0.0008
277 HYPOMAGNESAEMIA 11 0.0008
278 RESPIRATORY RATE INCREASED 7 0.0008
279 APHONIA 11 0.0008
280 ABDOMINAL INFECTION 2 0.0008
281 INCREASED BRONCHIAL SECRETION 2 0.0008
282 MEAN CELL VOLUME INCREASED 2 0.0008
283 EJECTION FRACTION DECREASED 12 0.0008
284 FEBRILE NEUTROPENIA 51 0.0008
285 PULMONARY HAEMORRHAGE 6 0.0008
286 COMPARTMENT SYNDROME 2 0.0008
287 VENOUS THROMBOSIS 3 0.0008
288 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
289 PNEUMONIA BACTERIAL 7 0.0008
290 ENURESIS 3 0.0007
291 EAR CONGESTION 2 0.0007
292 SPUTUM DISCOLOURED 7 0.0007
293 SHOCK HAEMORRHAGIC 6 0.0007
294 HYDROCEPHALUS 4 0.0007
295 HICCUPS 6 0.0007
296 NEPHROTIC SYNDROME 5 0.0007
297 DROOLING 5 0.0007
298 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
299 HEPATIC FUNCTION ABNORMAL 27 0.0007
300 DRUG ABUSE 60 0.0007
301 LUNG CONSOLIDATION 2 0.0007
302 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
303 BODY TEMPERATURE DECREASED 7 0.0007
304 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
305 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
306 NEUTROPENIC SEPSIS 5 0.0007
307 AGRANULOCYTOSIS 13 0.0007
308 HIATUS HERNIA 9 0.0007
309 CELLULITIS 35 0.0007
310 BLOOD URIC ACID INCREASED 4 0.0007
311 HYPONATRAEMIA 39 0.0007
312 DELIRIUM 24 0.0007
313 ADENOVIRUS INFECTION 2 0.0007
314 RALES 4 0.0007
315 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
316 BLOOD CALCIUM INCREASED 6 0.0007
317 HYPOVOLAEMIA 4 0.0007
318 VULVOVAGINAL DISCOMFORT 3 0.0007
319 PSYCHIATRIC SYMPTOM 5 0.0007
320 RASH MACULO-PAPULAR 15 0.0007
321 BRAIN HERNIATION 2 0.0007
322 INFUSION SITE REACTION 2 0.0007
323 ANAL INCONTINENCE 6 0.0007
324 PAIN 406 0.0007
325 DYSCHEZIA 2 0.0007
326 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
327 HYPERCALCAEMIA 8 0.0006
328 CEREBRAL HAEMORRHAGE 23 0.0006
329 ASPARTATE AMINOTRANSFERASE INCREASED 34 0.0006
330 FALL 213 0.0006
331 INJECTION SITE HYPERSENSITIVITY 2 0.0006
332 BLOOD CREATININE DECREASED 2 0.0006
333 MALAISE 278 0.0006
334 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
335 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
336 BLADDER PAIN 2 0.0006
337 MALNUTRITION 7 0.0006
338 ENTERITIS 4 0.0006
339 HYPOXIA 22 0.0006
340 ACUTE RESPIRATORY FAILURE 12 0.0006
341 ENTEROCOCCAL INFECTION 3 0.0006
342 BACTERIAL SEPSIS 2 0.0006
343 HYPOVENTILATION 2 0.0006
344 NEUTROPHIL COUNT DECREASED 25 0.0006
345 LYMPHOCYTE COUNT INCREASED 2 0.0006
346 NASAL POLYPS 3 0.0006
347 LEUKOCYTOSIS 11 0.0006
348 C-REACTIVE PROTEIN INCREASED 22 0.0006
349 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
350 EMBOLISM 5 0.0006
351 CARDIAC FAILURE ACUTE 4 0.0006
352 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
353 BK VIRUS INFECTION 2 0.0006
354 BACTERAEMIA 7 0.0006
355 HEPATIC CYST 2 0.0006
356 TACHYPNOEA 8 0.0006
357 PETIT MAL EPILEPSY 3 0.0006
358 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
359 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
360 DRUG INTERACTION 92 0.0006
361 CERVICAL VERTEBRAL FRACTURE 2 0.0006
362 PERIORBITAL OEDEMA 3 0.0006
363 DEPRESSION SUICIDAL 2 0.0006
364 MENTAL IMPAIRMENT 14 0.0006
365 DRUG-INDUCED LIVER INJURY 18 0.0006
366 HAEMOPTYSIS 16 0.0006
367 ALANINE AMINOTRANSFERASE INCREASED 35 0.0006
368 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
369 PNEUMOTHORAX 9 0.0006
370 DUODENAL ULCER 4 0.0006
371 NYSTAGMUS 3 0.0006
372 HYPOTHYROIDISM 18 0.0006
373 JAUNDICE 15 0.0006
374 INTESTINAL OBSTRUCTION 21 0.0006
375 BLOOD BILIRUBIN INCREASED 15 0.0006
376 ERYTHEMA OF EYELID 3 0.0006
377 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
378 DEVICE KINK 2 0.0005
379 HYPERGLYCAEMIA 20 0.0005
380 INTESTINAL ISCHAEMIA 3 0.0005
381 RESPIRATORY DISTRESS 15 0.0005
382 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
383 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
384 HYPOPHOSPHATAEMIA 4 0.0005
385 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
386 URINARY RETENTION 18 0.0005
387 CEREBRAL INFARCTION 13 0.0005
388 HEPATIC NECROSIS 2 0.0005
389 CHOLECYSTITIS ACUTE 3 0.0005
390 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
391 COMMUNICATION DISORDER 2 0.0005
392 LIPASE INCREASED 4 0.0005
393 ELECTROLYTE IMBALANCE 6 0.0005
394 APHTHOUS ULCER 4 0.0005
395 FAECES HARD 2 0.0005
396 HAEMORRHOIDS 10 0.0005
397 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
398 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
399 HYPOPHAGIA 13 0.0005
400 BRADYKINESIA 3 0.0005
401 COVID-19 PNEUMONIA 6 0.0005
402 FAECES DISCOLOURED 11 0.0005
403 PLATELET COUNT DECREASED 54 0.0005
404 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
405 CHOLECYSTITIS 6 0.0005
406 RENAL CYST 4 0.0005
407 RESPIRATORY TRACT CONGESTION 8 0.0005
408 PRESCRIBED UNDERDOSE 10 0.0005
409 DRUG INEFFECTIVE 658 0.0005
410 CANDIDIASIS 2 0.0005
411 RESPIRATORY FAILURE 36 0.0005
412 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
413 PARALYSIS 7 0.0005
414 ABNORMAL FAECES 4 0.0005
415 SPINAL COMPRESSION FRACTURE 4 0.0005
416 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
417 HYPERTHYROIDISM 7 0.0005
418 SECOND PRIMARY MALIGNANCY 4 0.0005
419 ABDOMINAL PAIN LOWER 12 0.0005
420 PROTEINURIA 9 0.0005
421 RENAL PAIN 5 0.0005
422 CIRCULATORY COLLAPSE 8 0.0005
423 HAEMOGLOBIN DECREASED 48 0.0005
424 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
425 MYOPATHY 4 0.0005
426 DYSURIA 17 0.0005
427 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
428 CHAPPED LIPS 2 0.0005
429 DIABETIC KETOACIDOSIS 11 0.0005
430 BLOOD GLUCOSE FLUCTUATION 5 0.0005
431 HAEMORRHAGIC ANAEMIA 2 0.0005
432 HYPOKALAEMIA 21 0.0005
433 MENINGITIS 3 0.0004
434 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
435 PANCYTOPENIA 25 0.0004
436 INTESTINAL PERFORATION 5 0.0004
437 BRONCHIECTASIS 3 0.0004
438 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
439 ACUTE HEPATIC FAILURE 6 0.0004
440 OFF LABEL USE 383 0.0004
441 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
442 NEPHROLITHIASIS 20 0.0004
443 LARGE INTESTINE POLYP 3 0.0004
444 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
445 LARGE INTESTINE PERFORATION 3 0.0004
446 AUTOIMMUNE HEPATITIS 3 0.0004
447 CONJUNCTIVITIS 8 0.0004
448 FEELING OF DESPAIR 2 0.0004
449 HEPATIC ENCEPHALOPATHY 4 0.0004
450 EPILEPSY 13 0.0004
451 CYTOMEGALOVIRUS INFECTION 7 0.0004
452 GASTRIC ULCER 8 0.0004
453 MYOCLONUS 5 0.0004
454 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
455 KIDNEY TRANSPLANT REJECTION 2 0.0004
456 MYELOSUPPRESSION 15 0.0004
457 HUMERUS FRACTURE 2 0.0004
458 NAUSEA 328 0.0004
459 HYPOKINESIA 6 0.0004
460 STOMATITIS 25 0.0004
461 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
462 THROMBOTIC MICROANGIOPATHY 4 0.0004
463 PARKINSONISM 4 0.0004
464 RESPIRATORY DEPRESSION 5 0.0004
465 SMALL INTESTINAL OBSTRUCTION 5 0.0004
466 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
467 MUCOUS STOOLS 2 0.0004
468 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
469 IMMUNODEFICIENCY 6 0.0004
470 HYPERAMMONAEMIA 2 0.0004
471 DERMATITIS EXFOLIATIVE 2 0.0004
472 ACUTE KIDNEY INJURY 61 0.0004
473 HYPERTHERMIA 3 0.0004
474 HEPATIC CYTOLYSIS 5 0.0004
475 AMMONIA INCREASED 2 0.0004
476 THIRST 7 0.0004
477 OVERDOSE 84 0.0004
478 ANOREXIA 5 0.0004
479 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
480 DELUSION 6 0.0004
481 VENTRICULAR EXTRASYSTOLES 4 0.0004
482 BLOOD CREATININE INCREASED 25 0.0004
483 LETHARGY 22 0.0004
484 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
485 CATATONIA 2 0.0004
486 PNEUMONIA 123 0.0004
487 HEAD INJURY 12 0.0004
488 PLEURAL EFFUSION 23 0.0004
489 ASCITES 11 0.0004
490 COMPRESSION FRACTURE 2 0.0004
491 ANAL FISSURE 2 0.0004
492 LOCALISED INFECTION 9 0.0004
493 MYASTHENIA GRAVIS 3 0.0004
494 TACHYCARDIA 33 0.0004
495 GINGIVITIS 2 0.0004
496 LACTIC ACIDOSIS 12 0.0004
497 URINARY TRACT INFECTION 63 0.0004
498 POST PROCEDURAL INFECTION 3 0.0004
499 ASPHYXIA 3 0.0004
500 HEADACHE 230 0.0004
501 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
502 DENTAL CARIES 4 0.0004
503 EOSINOPHIL COUNT INCREASED 3 0.0004
504 STEVENS-JOHNSON SYNDROME 8 0.0004
505 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
506 NECROSIS 2 0.0004
507 CANDIDA INFECTION 6 0.0004
508 EYE INFECTION 4 0.0004
509 HAEMATOCRIT DECREASED 7 0.0004
510 SUBDURAL HAEMATOMA 5 0.0003
511 ANURIA 3 0.0003
512 BLOOD MAGNESIUM DECREASED 3 0.0003
513 HERPES VIRUS INFECTION 2 0.0003
514 METASTASES TO LUNG 4 0.0003
515 CYSTITIS 11 0.0003
516 SEPTIC SHOCK 15 0.0003
517 METABOLIC DISORDER 2 0.0003
518 HYPERKALAEMIA 12 0.0003
519 HYPERTRIGLYCERIDAEMIA 2 0.0003
520 SPINAL OSTEOARTHRITIS 3 0.0003
521 PURPURA 3 0.0003
522 PERITONITIS 7 0.0003
523 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
524 COLON CANCER 5 0.0003
525 PRODUCT USE IN UNAPPROVED INDICATION 83 0.0003
526 HAEMOLYTIC ANAEMIA 3 0.0003
527 DERMATITIS 7 0.0003
528 HYPOAESTHESIA ORAL 5 0.0003
529 NEURALGIA 8 0.0003
530 INGUINAL HERNIA 2 0.0003
531 IRRITABLE BOWEL SYNDROME 7 0.0003
532 RETINAL DETACHMENT 3 0.0003
533 ABDOMINAL DISTENSION 34 0.0003
534 DRUG ABUSER 2 0.0003
535 ANGER 11 0.0003
536 DEVICE RELATED INFECTION 5 0.0003
537 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
538 CHOLANGITIS 2 0.0003
539 PHARYNGITIS 4 0.0003
540 THROMBOCYTOPENIA 36 0.0003
541 ERYTHEMA MULTIFORME 3 0.0003
542 TOOTH EXTRACTION 4 0.0003
543 INFUSION SITE EXTRAVASATION 2 0.0003
544 HAEMATURIA 11 0.0003
545 APPENDICITIS 3 0.0003
546 DIARRHOEA HAEMORRHAGIC 3 0.0003
547 ACUTE MYELOID LEUKAEMIA 5 0.0003
548 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
549 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
550 FLANK PAIN 3 0.0003
551 LEUKOPENIA 16 0.0003
552 ARTERIOSCLEROSIS 3 0.0003
553 HAEMATEMESIS 8 0.0003
554 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
555 SEPSIS 35 0.0003
556 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
557 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
558 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
559 HYPERCHOLESTEROLAEMIA 3 0.0003
560 SINUS BRADYCARDIA 3 0.0003
561 DECREASED APPETITE 72 0.0003
562 BLOOD POTASSIUM INCREASED 5 0.0003
563 MUCOSAL INFLAMMATION 8 0.0003
564 ASPERGILLUS INFECTION 2 0.0003
565 HYPOGAMMAGLOBULINAEMIA 2 0.0003
566 SHOCK 7 0.0003
567 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
568 HYPOTONIA 3 0.0003
569 OVARIAN CYST 3 0.0003
570 MENTAL DISORDER 13 0.0003
571 EMPHYSEMA 3 0.0003
572 SUBARACHNOID HAEMORRHAGE 3 0.0003
573 IMPAIRED GASTRIC EMPTYING 4 0.0003
574 ECCHYMOSIS 2 0.0003
575 HYPOGLYCAEMIA 14 0.0003
576 CHEST PAIN 53 0.0003
577 RASH MACULAR 10 0.0003
578 SCRATCH 3 0.0003
579 BRADYCARDIA 15 0.0003
580 MOVEMENT DISORDER 9 0.0003
581 DECREASED ACTIVITY 3 0.0003
582 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
583 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
584 SWELLING FACE 18 0.0003
585 SKIN LACERATION 3 0.0003
586 DYSPNOEA 156 0.0003
587 FAECES SOFT 2 0.0003
588 OESOPHAGITIS 3 0.0003
589 GASTROENTERITIS 4 0.0003
590 WOUND INFECTION 3 0.0003
591 INTENTIONAL UNDERDOSE 2 0.0003
592 HEPATITIS 7 0.0003
593 MOUTH HAEMORRHAGE 2 0.0003
594 MELAENA 6 0.0003
595 OEDEMA PERIPHERAL 33 0.0003
596 HAEMATOMA 7 0.0003
597 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
598 DUODENAL ULCER PERFORATION 2 0.0003
599 RESPIRATORY TRACT INFECTION 7 0.0003
600 INTERSTITIAL LUNG DISEASE 13 0.0003
601 ECZEMA 14 0.0003
602 RESPIRATORY DISORDER 8 0.0003
603 OXYGEN SATURATION DECREASED 15 0.0003
604 VOMITING 125 0.0003
605 BLOOD URINE PRESENT 5 0.0003
606 DERMATITIS CONTACT 3 0.0003
607 RHINORRHOEA 17 0.0003
608 NEUROPATHY PERIPHERAL 25 0.0003
609 MYOCARDITIS 3 0.0003
610 CHOLESTASIS 5 0.0003
611 SEIZURE 30 0.0003
612 RENAL FAILURE ACUTE 11 0.0003
613 FOOD ALLERGY 2 0.0003
614 OEDEMA 14 0.0003
615 EYELID OEDEMA 3 0.0003
616 APNOEA 2 0.0003
617 PLASMA CELL MYELOMA 10 0.0003
618 GASTROINTESTINAL INFLAMMATION 2 0.0003
619 AFFECTIVE DISORDER 2 0.0003
620 BLOOD IRON DECREASED 3 0.0003
621 DIVERTICULITIS 7 0.0003
622 HYPERLIPIDAEMIA 3 0.0003
623 ATRIAL FLUTTER 2 0.0003
624 WOUND 7 0.0003
625 BLOOD PRESSURE FLUCTUATION 6 0.0002
626 AGITATION 18 0.0002
627 BODY TEMPERATURE INCREASED 5 0.0002
628 RED BLOOD CELL COUNT DECREASED 7 0.0002
629 METASTASES TO BONE 4 0.0002
630 PANCREATIC CARCINOMA 7 0.0002
631 DYSPHAGIA 23 0.0002
632 DRUG LEVEL INCREASED 4 0.0002
633 SKIN DISORDER 8 0.0002
634 SECRETION DISCHARGE 3 0.0002
635 DYSPHONIA 14 0.0002
636 HALLUCINATION, VISUAL 5 0.0002
637 MUSCLE ATROPHY 3 0.0002
638 URINARY INCONTINENCE 7 0.0002
639 FACIAL PARALYSIS 2 0.0002
640 DEHYDRATION 31 0.0002
641 POOR QUALITY SLEEP 5 0.0002
642 INJECTION SITE INDURATION 3 0.0002
643 FLATULENCE 13 0.0002
644 EOSINOPHILIA 4 0.0002
645 GROIN PAIN 2 0.0002
646 TOOTH INFECTION 3 0.0002
647 COLD SWEAT 4 0.0002
648 LUNG INFILTRATION 2 0.0002
649 RENAL IMPAIRMENT 19 0.0002
650 DRUG ERUPTION 4 0.0002
651 TOOTH DISORDER 5 0.0002
652 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
653 QUALITY OF LIFE DECREASED 3 0.0002
654 GASTROINTESTINAL INFECTION 2 0.0002
655 DYSKINESIA 9 0.0002
656 OSTEOMYELITIS 4 0.0002
657 PALLOR 6 0.0002
658 PNEUMONITIS 6 0.0002
659 GASTROINTESTINAL CARCINOMA 2 0.0002
660 MUSCULAR WEAKNESS 25 0.0002
661 SOMNOLENCE 44 0.0002
662 BRAIN NEOPLASM 2 0.0002
663 IRON DEFICIENCY ANAEMIA 2 0.0002
664 ORAL DISCOMFORT 3 0.0002
665 POLLAKIURIA 9 0.0002
666 FEELING COLD 6 0.0002
667 COORDINATION ABNORMAL 3 0.0002
668 NECK PAIN 12 0.0002
669 EPISTAXIS 16 0.0002
670 HEPATIC CIRRHOSIS 4 0.0002
671 BLOOD SODIUM DECREASED 4 0.0002
672 SEASONAL ALLERGY 3 0.0002
673 ARRHYTHMIA 10 0.0002
674 PULMONARY EMBOLISM 20 0.0002
675 THERAPY INTERRUPTED 15 0.0002
676 SLEEP APNOEA SYNDROME 4 0.0002
677 PRODUCTIVE COUGH 10 0.0002
678 ANGINA PECTORIS 6 0.0002
679 INCREASED APPETITE 4 0.0002
680 HYPERTENSION 44 0.0002
681 COUGH 58 0.0002
682 DIARRHOEA 132 0.0002
683 HEPATOMEGALY 2 0.0002
684 ACUTE MYOCARDIAL INFARCTION 6 0.0002
685 LIGAMENT SPRAIN 2 0.0002
686 ABNORMAL BEHAVIOUR 8 0.0002
687 CATARACT 12 0.0002
688 PULMONARY MASS 3 0.0002
689 EXTRAPYRAMIDAL DISORDER 5 0.0002
690 AGEUSIA 5 0.0002
691 BLOOD POTASSIUM DECREASED 6 0.0002
692 CYTOKINE RELEASE SYNDROME 4 0.0002
693 HOT FLUSH 15 0.0002
694 HEPATIC FAILURE 6 0.0002
695 DIABETES MELLITUS 15 0.0002
696 LUNG INFECTION 3 0.0002
697 EYE DISCHARGE 2 0.0002
698 PULMONARY HYPERTENSION 4 0.0002
699 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
700 INJECTION SITE DISCOMFORT 2 0.0002
701 INJECTION SITE MASS 7 0.0002
702 EATING DISORDER 4 0.0002
703 LOSS OF CONSCIOUSNESS 24 0.0002
704 NASAL CONGESTION 11 0.0002
705 CARDIAC FAILURE 15 0.0002
706 HIP FRACTURE 6 0.0002
707 HYPOACUSIS 8 0.0002
708 IMPAIRED HEALING 6 0.0002
709 ASPIRATION 2 0.0002
710 SKIN LESION 5 0.0002
711 INJECTION SITE NODULE 2 0.0002
712 RESPIRATORY ARREST 5 0.0002
713 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
714 LIVER DISORDER 8 0.0002
715 FUNGAL INFECTION 6 0.0002
716 HYPERTENSIVE CRISIS 2 0.0002
717 CHILLS 21 0.0002
718 THROAT IRRITATION 8 0.0002
719 NEPHROPATHY TOXIC 2 0.0002
720 PANCREATITIS ACUTE 4 0.0002
721 FACE OEDEMA 3 0.0002
722 CHROMATURIA 4 0.0002
723 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
724 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
725 GASTRIC HAEMORRHAGE 2 0.0002
726 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
727 SYNCOPE 17 0.0002
728 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
729 HOSPITALISATION 26 0.0002
730 NEUTROPENIA 23 0.0002
731 WHEEZING 10 0.0002
732 GOUT 3 0.0002
733 HEPATITIS C 2 0.0002
734 COVID-19 29 0.0002
735 ADRENAL INSUFFICIENCY 2 0.0002
736 NOCTURIA 2 0.0002
737 BONE DISORDER 3 0.0002
738 RESTLESSNESS 6 0.0002
739 BACK PAIN 38 0.0002
740 LIVER INJURY 4 0.0002
741 ANAPHYLACTIC REACTION 9 0.0002
742 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
743 THROMBOSIS 13 0.0002
744 FEMUR FRACTURE 5 0.0002
745 HEPATIC ENZYME INCREASED 11 0.0002
746 HEPATIC STEATOSIS 3 0.0002
747 DISEASE PROGRESSION 19 0.0002
748 DRY MOUTH 13 0.0002
749 MUSCULOSKELETAL STIFFNESS 14 0.0002
750 ASTHENIA 60 0.0002
751 DYSARTHRIA 6 0.0002
752 HERPES ZOSTER 9 0.0002
753 INTRAOCULAR PRESSURE INCREASED 2 0.0002
754 POST PROCEDURAL COMPLICATION 3 0.0002
755 GLAUCOMA 3 0.0002
756 ABDOMINAL PAIN UPPER 32 0.0002
757 EAR PAIN 3 0.0002
758 CHOKING 3 0.0002
759 HAEMORRHAGE 16 0.0002
760 SPEECH DISORDER 8 0.0002
761 GASTRITIS 4 0.0002
762 IMMUNE SYSTEM DISORDER 2 0.0002
763 STAPHYLOCOCCAL INFECTION 5 0.0002
764 GAIT DISTURBANCE 29 0.0002
765 SINUS DISORDER 3 0.0002
766 ADVERSE REACTION 2 0.0002
767 BLOOD PRESSURE DECREASED 10 0.0002
768 PRODUCT USE ISSUE 28 0.0001
769 BRONCHITIS 11 0.0001
770 INTENTIONAL SELF-INJURY 3 0.0001
771 DYSGEUSIA 11 0.0001
772 FEEDING DISORDER 3 0.0001
773 TASTE DISORDER 3 0.0001
774 GINGIVAL BLEEDING 2 0.0001
775 RASH ERYTHEMATOUS 7 0.0001
776 HALLUCINATION 11 0.0001
777 RIB FRACTURE 3 0.0001
778 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
779 MENTAL STATUS CHANGES 4 0.0001
780 DEVICE OCCLUSION 2 0.0001
781 CEREBROVASCULAR ACCIDENT 24 0.0001
782 OSTEOARTHRITIS 6 0.0001
783 LYMPHOPENIA 2 0.0001
784 PAIN IN JAW 4 0.0001
785 RETCHING 3 0.0001
786 JOINT INJURY 3 0.0001
787 BRONCHOSPASM 2 0.0001
788 AGGRESSION 7 0.0001
789 SKIN CANCER 3 0.0001
790 INFECTION 20 0.0001
791 PRURITUS 53 0.0001
792 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
793 DYSSTASIA 4 0.0001
794 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
795 CONTUSION 13 0.0001
796 HEPATOTOXICITY 3 0.0001
797 INFLUENZA 15 0.0001
798 HAEMORRHAGE INTRACRANIAL 2 0.0001
799 ADVERSE DRUG REACTION 12 0.0001
800 ECONOMIC PROBLEM 2 0.0001
801 SUICIDE ATTEMPT 8 0.0001
802 URTICARIA 22 0.0001
803 HEART RATE INCREASED 13 0.0001
804 INSURANCE ISSUE 2 0.0001
805 CONFUSIONAL STATE 21 0.0001
806 DISORIENTATION 5 0.0001
807 METABOLIC ACIDOSIS 4 0.0001
808 ASTHMA 14 0.0001
809 LUNG DISORDER 6 0.0001
810 PAIN IN EXTREMITY 36 0.0001
811 ENCEPHALOPATHY 3 0.0001
812 OSTEOPOROSIS 5 0.0001
813 OSTEONECROSIS OF JAW 3 0.0001
814 CARDIAC ARREST 10 0.0001
815 RENAL FAILURE 16 0.0001
816 INSOMNIA 32 0.0001
817 BONE PAIN 7 0.0001
818 ABDOMINAL DISCOMFORT 20 0.0001
819 GASTRIC CANCER 3 0.0001
820 ERECTILE DYSFUNCTION 3 0.0001
821 DRUG RESISTANCE 3 0.0001
822 UNRESPONSIVE TO STIMULI 3 0.0001
823 MULTI-ORGAN FAILURE 2 0.0001
824 NIGHTMARE 4 0.0001
825 NEOPLASM PROGRESSION 4 0.0001
826 VERTIGO 7 0.0001
827 DEAFNESS 3 0.0001
828 LOCAL SWELLING 2 0.0001
829 MUSCULOSKELETAL PAIN 6 0.0001
830 TREMOR 19 0.0001
831 DEVICE USE ISSUE 2 0.0001
832 NEUROTOXICITY 2 0.0001
833 METASTASES TO LIVER 2 0.0001
834 HYPOAESTHESIA 17 0.0001
835 DEPRESSED MOOD 6 0.0001
836 ARTHRALGIA 46 0.0001
837 LIMB INJURY 3 0.0001
838 SKIN DISCOLOURATION 5 0.0001
839 ADVERSE EVENT 10 0.0001
840 NASOPHARYNGITIS 20 0.0001
841 OROPHARYNGEAL PAIN 10 0.0001
842 RASH 47 0.0001
843 RENAL DISORDER 5 0.0001
844 BACTERIAL INFECTION 2 0.0001
845 DIZZINESS 53 0.0001
846 FOOT FRACTURE 2 0.0001
847 CONDITION AGGRAVATED 32 0.0001
848 BLOOD PRESSURE INCREASED 16 0.0001
849 HYPERSOMNIA 3 0.0001
850 BLOOD GLUCOSE DECREASED 5 0.0001
851 LOWER LIMB FRACTURE 2 0.0001
852 HERNIA 2 0.0001
853 NEEDLE ISSUE 3 0.0001
854 INTENTIONAL PRODUCT MISUSE 9 0.0001
855 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
856 SURGERY 6 0.0001
857 VISION BLURRED 14 0.0001
858 ARTHRITIS 8 0.0001
859 LABORATORY TEST ABNORMAL 3 0.0001
860 BLOOD GLUCOSE INCREASED 19 0.0001
861 BURNING SENSATION 7 0.0001
862 IRRITABILITY 6 0.0001
863 FULL BLOOD COUNT DECREASED 2 0.0001
864 PSORIATIC ARTHROPATHY 4 0.0001
865 BONE MARROW FAILURE 2 0.0001
866 SUICIDAL IDEATION 9 0.0001
867 FATIGUE 76 0.0001
868 DRY SKIN 13 0.0001
869 INJECTION SITE WARMTH 2 0.0001
870 TREATMENT FAILURE 8 0.0001
871 NERVOUS SYSTEM DISORDER 3 0.0001
872 UNDERDOSE 7 0.0001
873 NERVOUSNESS 5 0.0001
874 CARDIO-RESPIRATORY ARREST 4 0.0001
875 PARAESTHESIA 15 0.0001
876 MOUTH ULCERATION 2 0.0001
877 LIVER FUNCTION TEST INCREASED 2 0.0001
878 UNEVALUABLE EVENT 7 0.0001
879 DEEP VEIN THROMBOSIS 6 0.0001
880 CHRONIC KIDNEY DISEASE 7 0.0001
881 DEVICE DISLOCATION 4 0.0001
882 CHOLELITHIASIS 3 0.0001
883 TREATMENT NONCOMPLIANCE 5 0.0001
884 PERIPHERAL SWELLING 14 0.0001
885 VISUAL ACUITY REDUCED 3 0.0001
886 VIRAL INFECTION 3 0.0001
887 LIP SWELLING 3 0.0001
888 ARTHROPATHY 5 0.0001
889 GAIT INABILITY 3 0.0001
890 GASTROINTESTINAL DISORDER 8 0.0001
891 CHEST DISCOMFORT 9 0.0001
892 ILLNESS 9 0.0001
893 MUSCLE TWITCHING 2 0.0001
894 BLOOD CHOLESTEROL INCREASED 4 0.0001
895 PALPITATIONS 10 0.0001
896 WEIGHT INCREASED 19 0.0001
897 LYMPHADENOPATHY 3 0.0001
898 JOINT SWELLING 10 0.0001
899 DRUG EFFECT INCOMPLETE 3 0.0001
900 CRYING 3 0.0001
901 PANIC ATTACK 3 0.0001
902 ATRIAL FIBRILLATION 8 0.0001
903 FEELING HOT 5 0.0001
904 ANXIETY 23 0.0001
905 EYE SWELLING 3 0.0001
906 DYSPNOEA EXERTIONAL 3 0.0001
907 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
908 DEPRESSION 18 0.0001
909 SINUSITIS 8 0.0001
910 DEVICE ISSUE 7 0.0001
911 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
912 DIPLOPIA 2 0.0001
913 DEATH 66 0.0001
914 MYALGIA 13 0.0001
915 JOINT STIFFNESS 2 0.0001
916 PANCREATITIS 4 0.0001
917 EAR INFECTION 2 0.0001
918 NEOPLASM MALIGNANT 5 0.0001
919 BREAST CANCER FEMALE 2 0.0001
920 CARDIAC FAILURE CONGESTIVE 6 0.0001
921 BLINDNESS 3 0.0001
922 MIGRAINE 7 0.0001
923 ROAD TRAFFIC ACCIDENT 3 0.0001
924 BLISTER 4 0.0001
925 SKIN EXFOLIATION 6 0.0001
926 INTENTIONAL DOSE OMISSION 2 0.0001
927 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
928 HYPERSENSITIVITY 13 0.0001
929 CONVULSION 4 0.0001
930 HYPERHIDROSIS 9 0.0001
931 EYE IRRITATION 4 0.0001
932 LIVER FUNCTION TEST ABNORMAL 2 0.0001
933 ANGIOEDEMA 3 0.0001
934 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
935 FEELING ABNORMAL 16 0.0001
936 THERAPY NON-RESPONDER 3 0.0001
937 APHASIA 2 0.0001
938 LACRIMATION INCREASED 2 0.0001
939 ALOPECIA 13 0.0001
940 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
941 CORONARY ARTERY DISEASE 2 0.0001
942 THERAPEUTIC RESPONSE DECREASED 4 0.0001
943 TINNITUS 3 0.0001
944 VISUAL IMPAIRMENT 8 0.0001
945 OCULAR HYPERAEMIA 3 0.0001
946 DRUG INTOLERANCE 6 0.0001
947 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
948 EYE DISORDER 2 0.0001
949 INFLUENZA LIKE ILLNESS 5 0.0001
950 DRY EYE 3 0.0001
951 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
952 FLUSHING 6 0.0001
953 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
954 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
955 INJURY 4 0.0001
956 SLEEP DISORDER 4 0.0001
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
958 RASH PRURITIC 3 0.0001
959 MUSCLE SPASMS 10 0.0001
960 EYE PAIN 3 0.0001
961 MYOCARDIAL INFARCTION 9 0.0001
962 MEMORY IMPAIRMENT 7 0.0001
963 INJECTION SITE HAEMORRHAGE 4 0.0001
964 ABORTION SPONTANEOUS 2 0.0000
965 EMOTIONAL DISTRESS 6 0.0000
966 DISCOMFORT 3 0.0000
967 INJECTION SITE PAIN 15 0.0000
968 LUNG NEOPLASM MALIGNANT 2 0.0000
969 INTENTIONAL OVERDOSE 3 0.0000
970 DEVICE LEAKAGE 2 0.0000
971 DISEASE RECURRENCE 2 0.0000
972 COMA 2 0.0000
973 SKIN BURNING SENSATION 3 0.0000
974 PRODUCT DOSE OMISSION ISSUE 12 0.0000
975 FLUID RETENTION 2 0.0000
976 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
977 INFLAMMATION 2 0.0000
978 DISTURBANCE IN ATTENTION 2 0.0000
979 MEDICATION ERROR 2 0.0000
980 EXPOSURE DURING PREGNANCY 2 0.0000
981 CARDIAC DISORDER 3 0.0000
982 AMNESIA 2 0.0000
983 PSORIASIS 4 0.0000
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
985 INJECTION SITE REACTION 2 0.0000
986 RHEUMATOID ARTHRITIS 3 0.0000
987 DRUG DEPENDENCE 4 0.0000
988 INCORRECT DOSE ADMINISTERED 5 0.0000
989 BREAST CANCER 2 0.0000
990 INJECTION SITE ERYTHEMA 2 0.0000
991 NO ADVERSE EVENT 2 0.0000